ENTITY
Haleon

Haleon (HLN LN)

13
Analysis
Health Care • United Kingdom
Haleon is a British multinational consumer healthcare company specializing in everyday health products. The company offers a broad portfolio including oral health products (e.g., Sensodyne, parodontax), pain relief (e.g., Panadol, Advil), vitamins, minerals, and supplements (e.g., Centrum), and respiratory and digestive health solutions. Haleon is headquartered in Weybridge, England, and was established as an independent company on July 18, 2022.
more
•04 May 2026 20:50•Broker

Pakistan Pharmaceuticals: Listed Pharma Profits Up 17% YoY In 1Q2026; Price Led Growth Momentum Continued

Pakistan listed pharmaceutical sector witnessed profitability of Rs10.1bn up by 17% YoY and down by 28% QoQ in 1Q2026. The YoY surge in profits is...

Logo
142 Views
Share
•10 Apr 2026 15:36•Broker

Pakistan Pharmaceuticals: Pakistan Listed Pharma Profits Surged 78% In 2025; Highest Ever Profitability In 2025

Pakistan listed pharmaceutical sector witnessed earnings growth of 78% YoY to Rs42.2bn in 2025, leading it to an all-time high profitability. The...

Logo
183 Views
Share
•08 Apr 2024 15:54•Broker

Pakistan Equity - Pharmaceuticals Sector; Court dismissed petition in favour of pharma companies

The Lahore High Court on April 02, 2024, disposed off the case in favour of the pharmaceutical industry and the stay order against deregulation...

Logo
393 Views
Share
•29 Jul 2026 03:39•Broker

AFT Pharmaceuticals Pipeline Prescribes Upside

AFT Pharmaceuticals (AFT) hosted a forward-looking investor day highlighting its attractive R&D pipeline. In the meantime, AFT’s operating...

Logo
117 Views
Share
x